New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:49 EDTICE, NYX, BRK.ANYSE received counter-bid with value below ICE offer, reportedly from Berkshire
In a regulatory filing this morning, IntercontinentalExchange (ICE) disclosed that during the run-up to its agreement to merge with NYSE Euronext (NYX), NYSE's advisers initiated contact with representatives of a large industrial and financial holding company, identified in the filing as “Company A,” that they believed would be interested in NYSE Euronext’s businesses. Company A presented an indicative proposal with a value lower than the ICE proposal, according to the filing, and Company A's proposal also required that NYSE Euronext must first sell its European derivatives business for a specified minimum price. According to CNBC's David Faber, Company A described in the filing is Berkshire Hathaway (BRK.A). In the filing, IntercontinentalExchange also said the agreed upon merger with NYSE is subject to the merger control jurisdiction of the national competition authorities in Portugal, Spain and the U.K. The companies stated they intend to request a referral of the merger to the European Commission, such that merger clearance is required from only the European Commission in the EU. ICE and NYSE expect to submit the notification form to the European Commission during the first half of 2013, the filing said. In morning trading, NYSE Euronext shares were virtually unchanged, while IntercontinentalExchange was up 18c, or 0.13%, to $135.00.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 25, 2015
10:01 EDTAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:28 EDTAAgilent upgraded to Buy from Neutral at BTIG
Subscribe for More Information
07:18 EDTAG Corp to hold annual meeting
Subscribe for More Information
February 19, 2015
09:09 EDTALeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
February 17, 2015
16:09 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.73
Subscribe for More Information
16:08 EDTAAgilent sees Q2 EPS 37c-41c, consensus $39c
Subscribe for More Information
16:07 EDTAAgilent reports Q1 EPS 41c, consensus 41c
Subscribe for More Information
15:32 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Devon Energy (DVN), consensus $1.05... Vornado Realty (VNO), consensus $1.23... Analog Devices (ADI), consensus 61c... FirstEnergy (FE), consensus 75c... CF Industries (CF), consensus $5.08... Agilent Technologies (A), consensus 41c... Cimarex Energy (XEC), consensus 82c... Flowserve (FLS), consensus $1.13... Fossil (FOSL), consensus $3.07... Rackspace (RAX), consensus 19c... Norwegian Cruise Line (NCLH), consensus 37c... Jack in the Box (JACK), consensus 87c... Cloud Peak Energy (CLD), consensus 7c... La-Z-Boy (LZB), consensus 38c... KAR Auction Services (KAR), consensus 29c... Owens & Minor (OMI), consensus 50c... Valmont Industries (VMI), consensus $1.65... Realty Income (O), consensus 66c.
February 16, 2015
10:54 EDTADako and Ono Pharmaceutical announce collaboration
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Ono Pharmaceutical announced a new partnership to develop a potential diagnostic test specifically for use with Opdivo in the treatment of non-small cell lung cancer, NSCLC. This test is being investigated for its diagnostic utility to determine which patients are most likely to respond to Opdivo.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use